Respiratory Syncytial Virus (RSV) infection is a leading cause of hospitalisations for Australian babies under 12 months of age. Infants in this age group are at the highest risk from this infection.
Our experienced immunisation team is offering both the maternal immunisation (Abrysvo) and infant long acting monoclonal antibody (Beyfortus/Nirsevimab) together with our partner Cabrini Health.
FREE walk-in appointments (no booking required) for
MATERNAL IMMUNISATION or INFANT MONOCLONAL ANTIBODY
| Malvern, Cabrini Mother & Baby Centre | |
| Mondays 1pm – 4:30 pm | 7, 14, 28 April 5, 12, 19, 26 May 2, 16, 23 June |
| Wednesdays 5:30pm – 7:00pm | 9, 16, 23, 30 April 7, 14, 21, 28 May 11, 18 June |
For further information about our RSV therapeutics program, or if you want to book a specific appointment to discuss with our immunisation specialists, please contact FITS Clinic on 03 9005 8508 or info@fitsclinic.com.
Currently pregnant or have a child under 12 months and not sure what to do? Read on below:
Vaccination for pregnant women
From 3 February 2025, the Australian Government’s National Immunisation Program (NIP) will provide one free RSV vaccine to the following eligible people:
- Pregnant women (at any age) at 28-36 weeks gestation
The vaccine will provide protection against RSV for their infant through the passing of antibodies from the mother to the unborn baby.
Infant Therapeutic Program
In Victoria, a complimentary infant RSV immunisation program to protect infants most at risk from severe RSV disease will run from 1 April to 30 September 2025.
Under the new program, a free long-acting RSV monoclonal antibody, Beyfortus™ (Nirsevimab), will be offered to eligible infants and young children. Refer to the diagram below for eligibility criteria for the infant program:
